Share

Nanjing Gaoke Company Limited Stocks

CN¥ 7.99Last Updated 28.04.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 2.02B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 7.99
Key Takeaways

Risk factor

Very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nanjing Gaoke Company Limited develops real estate properties in China. The company develops and sells commercial residential properties; and undertakes renovation of old communities, new roads, and mountain park construction projects. It also offers house construction, municipal engineering construction and supervision, landscaping construction and maintenance, sewage treatment, and water supply services; and property management, land development, engineering design, and environmental protection project construction services. In addition, the company is involved in the industrial investment, venture capital, securities, investment management, consulting, and other investment activities; and provision of financing services for small and medium-sized technology companies, and start entrepreneurship. Further, it engages in the production and sale of various Chinese and Western medicine preparations; medical and health care consulting and service activities; and provision of leasing houses. The company was founded in 1992 and is based in Nanjing, China.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EBITDA, ove

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks